RecruitingPhase 2Phase 3NCT03031210

Twice Daily Treatment With Amoxicillin for Non-severe Community Acquired Pneumonia.

Treatment of Non-severe Community Acquired Pneumonia With Twice Daily Compared to Thrice Daily Regimen- A Non-inferiority Pragmatic Randomized-controlled Trial.

Sponsor

St. Justine's Hospital

Enrollment

1,370 participants

Start Date

Jun 11, 2017

Study Type

INTERVENTIONAL

Conditions

Community-acquired Pneumonia

Summary

The aim of this study will be to evaluate whether a twice-daily antibiotic regimen is non-inferior to a thrice-daily regimen for the treatment of non-severe community acquired pneumonia in children presenting at a paediatric Emergency Department (ED).

Eligibility

Min Age: 3 MonthsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Amoxicillin for people with community-acquired pneumonia. The study is currently recruiting participants at 1 location. People eligible for this study include aged 3 Months to 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.